Shareholder Class Action

     Shareholders say directors of NRG Energy unreasonably rejected a $6.2 billion buyout offer from Exelon – 0.485 Exelon shares for each NRG share – in Delaware Chancery Court.

     Shareholders sued Omrix Pharmaceuticals in New York County Court, seeking to enjoin its acquisition by Johnson & Johnson.
     Directors of Transmeta Corp. unfairly capped the stock price in Novafora’s $255 million buyout offer, shareholders say in Santa Clara County Court, Calif.
     Reserve Management Co. inflated the price of its Reserve Short-Term Trust and Reserve Yield Plus mutual funds through false and misleading statements, shareholders claim in Manhattan Federal Court.

%d bloggers like this: